Den Europæiske Union - dansk - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil hydrochlorid - kolorektale neoplasmer - antineoplastiske midler - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

takeda france sas - mifamurtid - osteosarkom - immunostimulants, - mepact er indiceret hos børn, unge og unge voksne til behandling af højkvalificeret resektabel ikke-metastatisk osteosarkom efter makroskopisk fuldstændig kirurgisk resektion. det anvendes i kombination med postoperativ multi-agent kemoterapi. sikkerhed og virkning er blevet vurderet i studier af patienter fra 2 til 30 år ved første diagnose.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

zoetis belgium sa - oclacitinibmaleat - midler til dermatitis, undtagen kortikosteroider - hunde - - treatment of pruritus associated with allergic dermatitis in dogs. - treatment of clinical manifestations of atopic dermatitis in dogs.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - rifaximin - filmovertrukne tabletter - 200 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

norgine b.v. - rifaximin - filmovertrukne tabletter - 200 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - rifaximin - filmovertrukne tabletter - 200 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - rifaximin - filmovertrukne tabletter - 200 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratoriske syncytiale virusinfektioner - vacciner - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.